Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Clinical and Experimental Immunology
|
October 1, 1986
Inhibition of virus replication does not alter malignant rabbit fibroma virus-induced immunosuppression
D S Strayer, E Skaletsky, J L Leibowitz
The Journal of Biological Chemistry
|
September 5, 1993
Surfactant protein A-binding proteins. Characterization and structures
D S Strayer, S Yang, H H Jerng
Human Pathology
|
January 29, 1999
Whither human pathology?
D S Strayer, C S Foster, F Gorstein
Gene Therapy
|
November 3, 1998
Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent
R Kondo, M A Feitelson, D S Strayer
Experimental Cell Research
|
February 13, 2001
Natural protection from apoptosis by surfactant protein A in type II pneumocytes
M K White, V Baireddy, D S Strayer
Virology
|
December 1, 1991
Sequence and analysis of a portion of the genomes of Shope fibroma virus and malignant rabbit fibroma virus that is important for viral replication in lymphocytes
D S Strayer, H H Jerng, K O'Connor
Clinical and Experimental Immunology
|
January 1, 1991
Immunogenicity of surfactant. II. Porcine and bovine surfactants
D S Strayer, M Hallman, T A Merritt
Archives of Dermatology
|
November 1, 1982
Cutaneous Hodgkin's disease
C L Silverman, D S Strayer, T H Wasserman
American Journal of Respiratory and Critical Care Medicine
|
March 1, 1996
Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo
D S Strayer, E Herting, B Sun, et al.
Microbial Pathogenesis
|
September 1, 1990
Determinants of the ability of malignant fibroma virus to induce immune dysfunction and tumor dissemination in vivo
D S Strayer, K A Laybourn, H K Heard
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Clinical and Experimental Immunology
|
October 1, 1986
Inhibition of virus replication does not alter malignant rabbit fibroma virus-induced immunosuppression
D S Strayer, E Skaletsky, J L Leibowitz
The Journal of Biological Chemistry
|
September 5, 1993
Surfactant protein A-binding proteins. Characterization and structures
D S Strayer, S Yang, H H Jerng
Human Pathology
|
January 29, 1999
Whither human pathology?
D S Strayer, C S Foster, F Gorstein
Gene Therapy
|
November 3, 1998
Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent
R Kondo, M A Feitelson, D S Strayer
Experimental Cell Research
|
February 13, 2001
Natural protection from apoptosis by surfactant protein A in type II pneumocytes
M K White, V Baireddy, D S Strayer
Virology
|
December 1, 1991
Sequence and analysis of a portion of the genomes of Shope fibroma virus and malignant rabbit fibroma virus that is important for viral replication in lymphocytes
D S Strayer, H H Jerng, K O'Connor
Clinical and Experimental Immunology
|
January 1, 1991
Immunogenicity of surfactant. II. Porcine and bovine surfactants
D S Strayer, M Hallman, T A Merritt
Archives of Dermatology
|
November 1, 1982
Cutaneous Hodgkin's disease
C L Silverman, D S Strayer, T H Wasserman
American Journal of Respiratory and Critical Care Medicine
|
March 1, 1996
Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo
D S Strayer, E Herting, B Sun, et al.
Microbial Pathogenesis
|
September 1, 1990
Determinants of the ability of malignant fibroma virus to induce immune dysfunction and tumor dissemination in vivo
D S Strayer, K A Laybourn, H K Heard
Page
of 12